|
regulation of AIM2 inflammasome complex assembly
|
GO_0140971 |
[Any process that modulates the frequency, rate or extent of AIM2 inflammasome complex assembly.] |
|
AIM2 inflammasome complex assembly
|
GO_0140970 |
[The aggregation, arrangement and bonding together of a set of components to form the AIM2 inflammasome complex.] |
|
cellular detoxification of sulfide
|
GO_0140974 |
[Any process carried out at the cellular level that reduces or removes the toxicity of a sulfide. These may include chemical modification or transport of sulfide away from sensitive areas and to compartments or complexes whose purpose is sequestration of the toxic substance.] |
|
positive regulation of AIM2 inflammasome complex assembly
|
GO_0140973 |
[Any process that activates or increases the frequency, rate or extent of AIM2 inflammasome complex assembly.] |
|
negative regulation of AIM2 inflammasome complex assembly
|
GO_0140972 |
[Any process that stops, prevents or reduces the frequency, rate or extent of AIM2 inflammasome complex assembly.] |
|
intracellular nucleotide homeostasis
|
GO_0140979 |
[A homeostatic process involved in the maintenance of a steady state level of nucleotides within a cell.] |
|
mitochondrial large ribosomal subunit binding
|
GO_0140978 |
[Binding to a mitochondrial large ribosomal subunit.] |
|
cellular detoxification of acetone
|
GO_0140977 |
[Any process carried out at the cellular level that reduces or removes the toxicity of acetone. These may include chemical modification, for example to methylglyoxal.] |
|
defense response against perturbation of plasma membrane integrity
|
GO_0140976 |
[The cellular processes and signaling pathways by which a cell responds to disruption of the integrity of its plasma membrane by another organism. Some toxins produced by other organisms can form pores in membranes, or affect the membrane permeability.] |
|
determination of lung left/right asymmetry
|
GO_0140969 |
[Determination of the asymmetric location of the lungs with respect to the left and right halves of the organism.] |
|
intracellular auxin homeostasis
|
GO_0140964 |
[A homeostatic process involved in the maintenance of a steady state level of auxin within a cell.] |
|
obsolete multicellular organismal-level auxin homeostasis
|
GO_0140963 |
[OBSOLETE. A chemical homeostatic process involved in the maintenance of a steady state level of auxin within extracellular body fluids, such as the xylem or phloem of a multicellular organism. This is distinct from maintenance of cellular homeostasis, which occurs within a cell.] |
|
polyspecific organic cation:proton antiporter activity
|
GO_0140968 |
[Enables the transfer of various organic cations in exchange for a proton, according to the reaction: H+(out) + organic cation(in) = H+(in) + organic cation(out). The transported substrates are usually toxic molecules, drugs and xenobiotics.] |
|
manganese import into cell
|
GO_0140967 |
[The directed movement of mangnanese ions from outside of a cell into a cell.] |
|
secondary piRNA processing
|
GO_0140965 |
[A process leading to the generation of a functional secondary piRNA, involving a self-perpetuating piRNA loop, often called the ping-pong cycle, in which piRNAs are amplified by pairing with complementary transcripts (for example the transposable element mRNA target). In Drosophila, the processing involves the piwi proteins aubergine and Argonaute 3 and in mice, the piwi proteins Piwil2 and Piwil4.] |
|
obsolete base-pairing target-directed miRNA suppressor activity
|
GO_0140959 |
[OBSOLETE. An inhibitor activity that acts by base-pairing with a miRNA, exposing it to nuclease-mediated degradation.] |
|
target-directed miRNA degradation
|
GO_0140958 |
[The process in which a miRNA is targeted for degradation by a non-coding RNA or mRNA. The binding of an RNA to a target miRNA within a RISC complex results in either ubiquitin-mediated degradation of AGO protein or the displacement of the 3' end of the miRNA, exposing it to nucleases.] |
|
histone H3K27 monomethyltransferase activity
|
GO_0140953 |
[Catalysis of the reaction: L-lysyl27-[histone H3] + S-adenosyl-L-methionine = H+ + N6-methyl-L-lysyl27-[histone H3] + S-adenosyl-L-homocysteine. This reaction is the addition of a single methyl group to the unmethylated lysine residue at position 27 of histone H3, producing histone H3K27me.] |
|
histone H3K27 dimethyltransferase activity
|
GO_0140952 |
[Catalysis of the reaction: L-lysyl27-[histone H3] + 2 S-adenosyl-L-methionine = 2 H+ + N6,N6-dimethyl-L-lysyl27-[histone H3] + 2 S-adenosyl-L-homocysteine. This reaction is the successive addition of two methyl groups to the unmethylated lysine residue at position 27 of histone H3, producing histone H3K27me2.] |
|
histone H3K27 trimethyltransferase activity
|
GO_0140951 |
[Catalysis of the reaction: L-lysyl27-[histone H3] + 3 S-adenosyl-L-methionine = 3 H+ + N6,N6,N6-trimethyl-L-lysyl27-[histone H3] + 3 S-adenosyl-L-homocysteine. This reaction is the successive addition of three methyl groups to the unmethylated lysine residue at position 27 of histone H3, producing histone H3K27me3.] |